Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03707821
Other study ID # CR-6305
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date November 1, 2018

Study information

Verified date November 2019
Source Johnson & Johnson Vision Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a 2-visit, multi-site, partially subject-masked, 2-arm parallel, controlled, randomized and dispensing trial. Subjects will be randomized to one of two study lenses for the entire duration of the study. The study lenses will be worn for a period of 2 weeks each in a bilateral fashion.


Recruitment information / eligibility

Status Completed
Enrollment 253
Est. completion date November 1, 2018
Est. primary completion date November 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria:

- Potential subjects must satisfy all of the following criteria to be enrolled in the study:

1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.

2. Appear able and willing to adhere to the instructions set forth in this clinical protocol.

3. Between 18 and 49 (inclusive) years of age at the time of informed consent.

4. Eligible presbyopes will be those that wear full distance contact lenses in both eyes, then wear reading glasses over them when needed for near vision.

5. The subject is a current spherical soft contact lens wearer in both eyes with a minimum of 6 hours/day and 5 days/week wear time over the last 30 days by self-report.

6. Subjects must be able and willing to wear the study lenses at least 6 hours a day, a minimum of 5 days per week.

7. Subjects must own a wearable pair of distance spectacles.

8. The subject's vertex-corrected spherical equivalent distance refraction must be in the range of -1.00 to -6.00 D (inclusive) in each eye.

9. The subject's refractive cylinder must be 0.00 to -1.00 D (inclusive) in each eye.

10. The subject must have a spherocylindrical best corrected distance Snellen visual acuity of 20/25+3 or better in each eye.

Exclusion Criteria:

- Potential subjects who meet any of the following criteria will be excluded from participating in the study:

1. Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).

2. Any active or ongoing systemic disease (e.g., Sjögren's Syndrome), infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis).

3. Subjects taking suspect oral medications for less than one year.

4. Any prescribed or over the counter (OTC) ocular medication.

5. Any known hypersensitivity or allergic reaction to Optifree® PureMoist® multi-purpose care solution or Eye-Cept® rewetting drop solution.

6. Toric, extended wear, monovision or multi-focal contact lens correction.

7. Any previous or planned (during the course of the study) ocular surgery (e.g., PRK, LASIK, etc.).

8. Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.

9. Participation in clinical trials involving the Test lens within 3 months prior to study enrollment.

10. Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).

11. Binocular vision abnormality or strabismus by self-report or prior medical history.

12. History of recurrent corneal erosions, herpetic keratitis, or pathological dry eye.

13. Any active ocular allergies, infections or other ocular abnormalities (entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma) that the investigator determines may interfere with the outcomes of this study or otherwise contraindicate participation in the study.

14. Any Grade 2 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA Slit Lamp Classification Scale.

15. Any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar) within the past 3 years of otherwise successful contact lens wear.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
senofilcon A TEST Lens
JJVC Investigational Contact Lens
senofilcon A CONTROL Lens
Acuvue Oasys

Locations

Country Name City State
United States Eyecare Associates LLP Bloomington Illinois
United States James T. Fujimoto, OD Cupertino California
United States ProCare Vision Centers Granville Ohio
United States Maitland Vision Center Maitland Florida
United States Bradley Hines, OD Memphis Tennessee
United States Ziegler Leffingwell Eyecare New Berlin Wisconsin
United States Kannarr Eye Care Pittsburg Kansas
United States Tallahassee Eye Center Tallahassee Florida
United States Frazier Vision, Inc Tyler Texas
United States Professional Vision Care, Inc Westerville Ohio

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Vision Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Comfort Score Overall comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patientexperience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. 2-Week Follow-up Evlauation
Primary Vision Satisfaction in Bright Lighting Vision satisfaction in bright light was assessed using the individual item" I was satisfied with the quality of my vision in bright lighting" from the CLUE™ questionnaire. This item used the response scale, 1: Strongly Disagree, 2: Disagree, 3: Neither Agree nor Disagree, 4: Agree and 5: Strongly Agree. CLUE is the Contact Lens User Experience™ questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The Proportion of responses in each category were reported for each lens type. 2-Week Follow-up Evaluation
Primary Distance Visual Acuity Distance visual acuity was assessed by eye using LogMAR visual acuity at 4 meters using an ETDRS chart under high illumination high contrast conditions (room illumination > 400 lux and chart luminance 120-200 cd/m2) at the 2-week follow-up for each subject eye. Lower values of logMAR indicate better vision, where a score of 0.0 equates to 20/20 snellen vision. The average visual acuity for each lens was reported. 2-Week Follow-up Evlauation
Primary Contact Lens Fitting Acceptance Rate Acceptable lens fit will be assessed at all study visits (scheduled and unscheduled) for each subject eye. Fit acceptance rate will be based on the lens fit acceptance of eyes wearing the Test lens only. Fit acceptance is a binary response where Y=1 if lens fit is acceptable and Y=0 otherwise. Unacceptable is defined as unacceptable if any one of the following criteria:
limbal exposure at primary gaze or with extreme eye movement;
edge lift;
excessive movement in primary up gaze;
insufficient movement in all three of the following conditions: primary gaze, up gaze, and push up test.
Eyes with multiple unacceptable fitting events will be counted only once. Fit rates of the Control lens will also be collected but are not a primary endpoint.
Up to 2-Week Follow-up
Primary Number of Grade 3 or Higher Slit Lamp Findings Slit Lamp Findings (SLF) were assessed using a biomicroscope and was graded using the FDA grading scale (Grade: 0, 1,2, 3 and 4) with grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e. Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). Slit Lamp Findings will be assessed for each subject eye at all study visits (schedule and unscheduled). SLF is a binary response where Y=1 for at least one Grade 3 or 4 slit lamp finding. The percentage of eyes with Grade 3 or higher slit lamp findings will be analyzed and will include corneal infiltrates. Eyes with multiple events will be counted only once. The number of eyes with SLF with grade 3 or higher by lens was reported. Up to 2-Week Follow-up Evlauation
Secondary Overall Handling Score Overall handling was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patientexperience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. 2-Week Follow-up Evlauation
Secondary Overall Quality of Vision Score Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patientexperience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. 2-Week Follow-up Evlauation
See also
  Status Clinical Trial Phase
Completed NCT06019806 - Effects of Forward Head Posture Correction on Visual Acuity in Low Level Visually Impaired University Students N/A
Completed NCT04567186 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic Population N/A
Completed NCT02568254 - Evaluation of Three Daily Disposable Contact Lenses N/A
Completed NCT01951703 - Senofilcon A Investigational Manufacturing Process N/A
Terminated NCT00637468 - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Phase 3
Recruiting NCT04632901 - A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
Active, not recruiting NCT03747601 - Temporal Interference Brain Stimulation N/A
Completed NCT06131476 - Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop Phase 1
Recruiting NCT05414565 - Post-Market Study of Alcon Intraocular Lenses
Completed NCT05056870 - Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats N/A
Completed NCT04615507 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2 N/A
Completed NCT05099380 - Validation of Senofilcon A With New UV / HEV Filter N/A
Completed NCT03713281 - Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population
Completed NCT05582304 - Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study N/A
Completed NCT03742271 - Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population N/A
Completed NCT04995055 - Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function N/A
Completed NCT05554640 - Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses N/A
Completed NCT01926704 - MTF Image Modifications N/A
Completed NCT04649606 - Dynamic Characterisation of Meibomian Gland Structure
Completed NCT05101252 - Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product N/A